Esophageal Cancer Missed Behind an Oregon Reflux Diagnosis

Heartburn is treated as a nuisance, and for many people that is what it is. The difficulty is that the early symptoms of esophageal and gastric cancer can look like reflux, and reflux has an effective treatment that relieves symptoms without telling anyone what is underneath them.

A proton pump inhibitor can quiet the burning while the reason for it goes unexamined. That is the shape of the cases worth a close look: years of refills, no endoscopy, and a diagnosis that arrives only when swallowing becomes difficult.

The eight-week trial, and what it assumes

There is a defined starting point for uncomplicated reflux. The American College of Gastroenterology's 2022 guideline recommends an eight-week trial of an empiric proton pump inhibitor, once daily before a meal, for a patient with classic GERD symptoms and no alarm symptoms.¹ If the symptoms do not respond adequately to that trial, the guideline recommends diagnostic endoscopy, ideally after the PPI has been stopped for two to four weeks.¹

Read that sequence carefully, because it contains its own exit. The empiric trial is the path for a patient without alarm symptoms, and it is bounded at eight weeks with a defined next step. It is not a standing prescription renewed indefinitely.

Alarm features change the sequence

The guideline sets out a different first move when certain features are present. Recommendation 6 states: "We recommend endoscopy as the first test for evaluation of patients presenting with dysphagia or other alarm symptoms (weight loss and GI bleeding) and for patients with multiple risk factors for Barrett's esophagus." The ACG grades that as a strong recommendation on a low level of evidence.¹

The American Society for Gastrointestinal Endoscopy reached the same place in its 2025 guideline. Its Recommendation 1a(I) states that in patients with GERD symptoms, the ASGE "recommends upper endoscopy in those with • Alarm symptoms (dysphagia, odynophagia, weight loss, GI bleeding, persistent vomiting, or unexplained iron deficiency anemia)," graded a strong recommendation on moderate-quality evidence.² The ASGE's conditional language attaches to different questions: it suggests endoscopy for patients who have Barrett's risk factors but no alarm symptoms, and for patients with a history of sleeve gastrectomy or peroral endoscopic myotomy.²

So two societies, reviewing the evidence separately, both put endoscopy first when an alarm feature is present, and both grade that recommendation strong. The ASGE's list is the longer one, adding odynophagia, persistent vomiting and unexplained iron deficiency anemia; the ACG also names vomiting and anemia in its discussion of who warrants endoscopy.¹ A patient who reports any of these is no longer inside the eight-week empiric pathway.

Barrett's esophagus, and what the delay costs

The reason this sequence exists is what chronic reflux can become. The ACG's 2022 Barrett's esophagus guideline states that Barrett's esophagus "is the only known precursor to esophageal adenocarcinoma, a highly lethal cancer with an increasing incidence over the last 5 decades."³

That is the whole argument for looking. Barrett's is a condition the endoscope can find and then follow on a surveillance schedule. An adenocarcinoma discovered because swallowing has become difficult is a different clinical problem from a dysplastic segment found on a scheduled surveillance endoscopy.

Patterns that raise the question in a medical negligence review include these. Alarm features appear in the chart and the prescription is renewed. An eight-week trial becomes an eight-year one with no endoscopy and no documented reassessment. An endoscopy is recommended, the referral is never made, and nothing follows up when the appointment does not happen. A patient reports new difficulty swallowing and is told to take the medication before meals instead.

What Oregon law measures

A guideline and a legal duty are separate things, and Oregon states the duty by statute.

Under ORS 677.095(1), a physician licensed to practice medicine or podiatry by the Oregon Medical Board has "the duty to use that degree of care, skill and diligence that is used by ordinarily careful physicians in the same or similar circumstances in the community of the physician or a similar community."⁴ Subsection (2) states the same kind of duty for a physician associate licensed by the board, measured against ordinarily careful physician associates.⁴

The statute is written in terms of practice — what ordinarily careful physicians do in the same or similar circumstances, in that community or a similar one. A published guideline is a document; the statutory question is about conduct. Establishing what the guidance said at the time of the care is the starting point, not the conclusion.

The deadline, and the word that does the work

ORS 12.110(4) provides that an action for injuries "arising from any medical, surgical or dental treatment, omission or operation shall be commenced within two years from the date when the injury is first discovered or in the exercise of reasonable care should have been discovered."⁵

The word carrying the weight there is "injury," and it does not mean what it sounds like. Under Gaston v. Parsons, 318 Or 247, 864 P2d 1319 (1994), "injury" as used in ORS 12.110(4) consists of harm, causation and tortious conduct.⁶ The two-year period does not begin until the patient knows, or in the exercise of reasonable care should know, facts that would make a reasonable person aware of a substantial possibility that all three exist. The court placed that standard between two positions it rejected: actual knowledge of each element is not required, and a mere suspicion is not enough.⁷

That distinction matters in a reflux case. A patient can know he has esophageal cancer, and know he took a PPI for years, without yet having reason to be aware of a substantial possibility that the years of refills without endoscopy were tortious.

The same subsection sets an outer limit. It provides that "notwithstanding the provisions of ORS 12.160, every such action shall be commenced within five years from the date of the treatment, omission or operation upon which the action is based …". Where there has been no action commenced within five years because of fraud, deceit or misleading representation, the statute allows suit "within two years from the date such fraud, deceit or misleading representation is discovered or in the exercise of reasonable care should have been discovered."⁵

Note what the five-year limit runs from: the date of the treatment or omission, not the date of discovery. In a case built on years of repeat prescribing, identifying which omission the claim rests on is part of the deadline analysis rather than separate from it.

Getting a case reviewed

Whether a delayed esophageal or gastric cancer diagnosis supports a claim depends on what the records show: what symptoms were reported and when, whether alarm features were documented, whether endoscopy was recommended or performed, and whether the delay changed the stage at which treatment began. Those are questions for a review of the actual records by qualified experts.

If you are concerned that years of reflux treatment went by without anyone looking, an Oregon attorney can review the records and the timeline with you.

This article is educational

This article describes Oregon law in general terms. It is not legal advice and does not create an attorney-client relationship.

Time limits matter. Most Oregon personal-injury and auto-accident claims must be filed within two years of the injury or accident. Medical malpractice claims must be filed within two years of when you knew or reasonably should have known of the negligence, with an outer limit of five years from the act itself (with a fraud exception). Wrongful death claims must be filed within three years of the date of death. Claims against public bodies (cities, counties, state agencies, public hospitals) require a notice of claim within 180 days. Missing these deadlines typically ends a case.

If you think you may have a claim, call Huegli Law at 971-317-6436 for a free case review. Todd Huegli is licensed in Oregon and consults on cases in Oregon only.

Footnotes

1. Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 2022;117(1):27–56. https://doi.org/10.14309/ajg.0000000000001538 ↩ ↩² ↩³ ↩⁴

2. American Society for Gastrointestinal Endoscopy guideline on the diagnosis and management of GERD: summary and recommendations. Gastrointest Endosc. 2025;101(2):267–284. https://doi.org/10.1016/j.gie.2024.10.008 ↩ ↩²

3. Shaheen NJ, Falk GW, Iyer PG, et al. Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. Am J Gastroenterol. 2022;117(4):559–587. https://doi.org/10.14309/ajg.0000000000001680 ↩

4. ORS 677.095 (Duty of care). Oregon State Legislature. https://www.oregonlegislature.gov/bills_laws/ors/ors677.html ↩ ↩²

5. ORS 12.110 and ORS 12.160 (ORS chapter 12 — limitations of actions). Oregon State Legislature. https://www.oregonlegislature.gov/bills_laws/ors/ors012.html ↩ ↩²

6. Oregon Revised Statutes Annotations — ORS 12.110 (Gaston v. Parsons). Oregon State Legislature. https://www.oregonlegislature.gov/bills_laws/ors/ano012.html ↩

7. Gaston v. Parsons, 318 Or 247 (1994) — opinion text, Oregon Reports, digitised by the Caselaw Access Project. https://static.case.law/or/318/cases/0247-01.json ↩